Epidemiology of hip fractures in Bulgaria : development of a country-specific FRAX model by Kirilova, E. et al.
This is a repository copy of Epidemiology of hip fractures in Bulgaria : development of a 
country-specific FRAX model.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/159191/
Version: Published Version
Article:
Kirilova, E., Johansson, H., Kirilov, N. et al. (9 more authors) (2020) Epidemiology of hip 
fractures in Bulgaria : development of a country-specific FRAX model. Archives of 
Osteoporosis, 15 (1). 28. ISSN 1862-3522 
https://doi.org/10.1007/s11657-020-0710-2
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
ORIGINAL ARTICLE
Epidemiology of hip fractures in Bulgaria: development
of a country-specific FRAX model
E. Kirilova1 & H. Johansson2 & N. Kirilov1 & S. Vladeva3 & T. Petranova1 & Z. Kolarov1 & E. Liu2 & M. Lorentzon2,4 &
L. Vandenput2,5 & N. C. Harvey6 & E. McCloskey7 & John A. Kanis2,7
Received: 11 November 2019 /Accepted: 29 December 2019
# The Author(s) 2020
Abstract
Summary
A retrospective population-based survey was undertaken in a region of Bulgaria to determine the incidence of hip fracture. The
estimated number of hip fractures nationwide for 2015 was 9322 and is predicted to increase to 11,398 in 2050. The hip fracture
rates were used to create a FRAX model.
Objective
To describe the epidemiology of hip fractures in Bulgaria, whichwas then used to develop the country-specific fracture prediction
FRAX® tool.
Methods
We carried out a retrospective population-based survey in Stara Zagora, Bulgaria, representing approximately 4.6% of the
country’s population. We identified hip fractures occurring in 2015, 2016 and 2017 from hospital registers and primary care
sources held by the regional health insurance agency. Age- and sex-specific incidence of hip fracture and national mortality rates
were incorporated into a FRAX model for Bulgaria. Fracture probabilities were compared with those from neighbouring
countries having FRAX models.
Results
The incidence of hip fracture applied nationally suggested that the estimated number of hip fractures nationwide in persons over
the age of 50 years for 2015 was 9322 and is predicted to increase to 11,398 in 2050. FRAX-based probabilities were higher in
Bulgaria than those in Serbia or Romania, lower than those in Turkey and similar to those in Greece.
Conclusion
The FRAX model should enhance accuracy of determining fracture probability among the Bulgarian population and help guide
decisions about treatment.
Keywords Bulgaria . FRAX . Fracture probability . Epidemiology . Hip fracture
Introduction
Osteoporosis and osteoporotic fractures are becoming more
common with advancing age. In Europe, the annual cost of
fractures associated with osteoporosis exceeded € 37 billion in
2010 [1], and disability due to osteoporosis was greater than
that caused by any single cancer, with the exception of lung
cancer and was comparable or greater than that lost to a variety
* John A. Kanis
w.j.pontefract@sheffield.ac.uk
1 Medical University of Sofia, Sofia, Bulgaria
2 Mary MacKillop Institute for Health Research, Australian Catholic
University, Melbourne, Australia
3 Medical Faculty, Trakia University, Stara Zagora, Bulgaria
4 Geriatric Medicine, Institute of Medicine, University of Gothenburg,
Gothenburg, Sweden
5 Centre for Bone and Arthritis Research, Institute of Medicine,
University of Gothenburg, Gothenburg, Sweden
6 MRC Lifecourse Epidemiology Unit, University of Southampton,
Southampton, UK
7 Centre for Metabolic Bone Diseases, University of Sheffield,
Sheffield, UK
Archives of Osteoporosis           (2020) 15:28 
https://doi.org/10.1007/s11657-020-0710-2
of chronic non-communicable diseases, such as rheumatoid
arthritis, asthma and high blood pressure–related heart disease
[2]. Fortunately, a wide variety of treatments is available that
favourably affect bone mass and thereby decrease the risk of
fractures associated with osteoporosis [3]. The use of such
interventions by healthcare practitioners is assisted by instru-
ments that assess patients’ fracture risk to optimise clinical
decisions about prevention and treatment. The most widely
used web-based tool FRAX® (https://www.sheffield.ac.uk/
FRAX/) meets these requirements and computes the 10-year
probability of fragility fractures based on several common
clinical risk factors and optionally, a DXA scan result [4, 5].
FRAX models are available for 66 countries covering more
than 80% of the world population at risk [6] and have been
incorporated into more than 100 guidelines worldwide [7].
The availability of FRAX has stimulated studies for the
generation of new FRAX models. Specific examples include
Brazil, Mexico, Turkey [8–10] and several countries in
Eastern Europe [11–14]. The present report describes the ep-
idemiology of fractures at the hip in Bulgaria and the genera-
tion of a country-specific FRAX model.
Methods
Bulgaria is a country in Southeastern Europe with a total area
of 110,994 km2. It borders the Black Sea to the east, Greece
and Turkey to the south, Serbia andMacedonia to the west and
Romania to the north [15]. According to the national statistical
institute, the Bulgarian population comprises four ethnic
groups as follows: Bulgarian (84.8%), Turkish (8.8%),
Roma (4.9%) and others (1.5%) [16].
Stara Zagora, in Southern Bulgaria, is the sixth-largest city
in Bulgaria. Based on regional health inspection’s data, the
region’s population aged 40 years or above in 2017 amounted
to 183,294 people (84,557 men and 98,737 women) and rep-
resented 4.6% of the whole Bulgarian population aged
40 years and above (183,294/3,982,770). The ethnic admix-
ture of Stara Zagora is similar to the country as a whole.
We analysed the cases of hip fractures (ICD codes: S72.0,
S72.1 and S72.2) in the Stara Zagora region, Bulgaria, for the
years 2015, 2016 and 2017. Data were provided by the
Regional Health Insurance Fund (RHIF) Stara Zagora using
an electronic database of hospitals, general practitioners and
specialists in this region. The insurance company covers
81.2% of the total population but coverage varies according
to age and sex. The relevant data on coverage was available
and the age- and sex-specific insured population comprised
the denominator for the calculation of incidence. To minimise
double counting, further admissions for the same hip fracture
site within 3 months were excluded. Permanent residence in
the region was not a criterion for inclusion, so a small number
of patients living temporarily in the catchment area were also
included in the database.
Incidence of hip fractures was calculated from the age of
40 years in 5-year age intervals in men and in women. The age
of 40 was chosen since FRAX permits the calculation of frac-
ture probability from this age.
The age- and sex-specific incidence for 2015–2017 was
applied to the Bulgarian population for 2015 to estimate the
number of hip fractures nationwide. Additionally, future pro-
jections were estimated up to 2050, assuming that the age- and
sex-specific incidence remained stable. Population demogra-
phy was taken from the United Nations using the medium
variant for fertility [17].
The data on hip fracture were used to construct a FRAX
model for Bulgaria. For other major osteoporotic fractures
(clinical spine, forearm and humeral fractures), it was assumed
that the age- and sex-specific ratios of these fractures to hip
fracture risk in Bulgaria were comparable with those found in
Sweden [4]. This assumption has been used for many of the
FRAX models with incomplete epidemiological information
on non-hip fractures. Available information suggests that the
age- and sex-stratified pattern of fracture is very similar in the
Western world and Australia [14, 18–20].
The development and validation of FRAX have been ex-
tensively described [4, 5]. The risk factors used were based on
a systematic set of meta-analyses of population-based cohorts
worldwide and validated in independent cohorts with over 1
million patient-years of follow-up. The construct of the FRAX
model for Bulgaria retained the beta coefficients of the risk
factors in the original FRAXmodel with the incidence rates of
hip fracture and mortality rates for Bulgaria. National mortal-
ity rates used data from the United Nations in 2014 [21]. Ten-
year fracture probabilities were compared with those of
neighbouring countries with FRAX models (Greece, Serbia,
Turkey and Romania).
In order to compare Bulgarian hip fracture probabilities
with those of other regions of the world, the remaining lifetime
probability of hip fracture from the age of 50 years was cal-
culated for men and women as described by Kanis et al. [22].
In the present analysis, values for Bulgaria were compared
with those of China (with and without inclusion of Hong
Kong), Canada, Denmark, Finland, France, Greece,
Hungary, Portugal, Spain, Sweden, UK and the USA [22],
with more recent additions from Mexico [23], Romania [24],
Poland [25], Moldova [14], Russia [12], Turkey [10], Ukraine
[26] and Serbia [27].
Results
A total of 367 hip fractures were identified in men and 1017 in
women (female/male ratio 2.8). Below the age of 65 years, hip
fractures were more prevalent in men than in women (female/
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male ratio 0.7), but thereafter were more frequent in women
(female/male ratio 3.2). The incidence of hip fracture in-
creased with age in men and women, though more markedly
in women (Table 1).
Hip fracture projections
Assuming that the fracture rates in Stara Zagora were repre-
sentative for the whole country and based on the UN estimates
of the Bulgarian population for 2015, we estimated that the
annual number of hip fractures in men and women aged
50 years and older in Bulgaria in 2015 was 9322, comprising
2521 in men and 6801 fractures in women. The number of hip
fractures is expected to increase progressively by calendar
year with an increase of 22% by 2050 (Table 2). The increase
in hip fracture numbers was higher in women (24% in women
and 18% in men) due to the high age dependency of hip
fracture incidence.
Fracture probability
The 10-year probability of major osteoporotic fracture and hip
fracture in Bulgaria and neighbouring countries is shown in
Table 3 in women with a prior fracture by age. Ten-year prob-
abilities were consistently higher than those in the
neighbouring countries of Serbia and Romania, lower than
those in Turkey and similar to those in Greece.
For the remaining lifetime probability of a hip fracture in
Bulgarian women from the age of 50 years was 11.2% which
lay midway between Romania and Serbia (7.1 and 7.7%,
Table 1 Population of the catchment area, number of hip fractures and
annual incidence of hip fractures (rate/100,000) in men and women in
Stara Zagora, Bulgaria, by age for years 2015, 2016 and 2017 combined
Age (years) Populationa Fracturesb Incidence/
100,000
95% CI
Men
40–44 28,257 9 32 15–60
45–49 27,267 14 51 28–86
50–54 26,372 18 68 40–108
55–59 27,646 26 94 61–138
60–64 27,889 35 125 87–175
65–69 27,903 37 133 93–183
70–74 20,886 44 211 153–283
75–79 15,632 54 345 259–451
80–84 11,131 54 485 364–633
85–89 4832 53 1097 822–1435
90+ 1292 23 1780 1128–2672
40+ 219,106 367 167 151–186
Women
40–44 28,069 3 11 2–31
45–49 26,998 7 26 10–53
50–54 27,768 12 43 22–76
55–59 30,383 24 79 51–118
0–64 34,907 36 103 72–143
65–69 38,011 60 158 120–203
70–74 30,842 95 308 249–377
75–79 24,652 189 767 661–884
80–84 19,278 261 1354 1195–1529
85–89 9247 247 2671 2348–3026
90+ 2862 83 2900 2310–3595
40+ 273,018 1017 373 350–396
a Population corrected for insurance cover
b Fractures per year over 3 years
Table 2 Estimated total number of hip fractures (ICD-10 codes S72.0,
S72.1, S72.2) in men and in women aged 50 years and older in 2015
projected up to 2050 in Bulgaria
2015 2020 2030 2040 2050
Men 2521 2567 2739 2903 2973
Women 6801 7136 7923 8397 8425
Total 9322 9703 10,662 11,300 11,398
Increase (%) - 4 14 21 22
Table 3 Ten-year probability of a major osteoporotic fracture (MOF)
and hip fracture in women with a prior fracture by age from Bulgaria,
Greece, Turkey, Serbia and Romania. Body mass index set to 25 kg/m2
Bulgaria Greece Turkey Serbia Romania
MOF
50 7.7 5.2 8.2 4.5 5.2
55 8.5 7.0 8.2 6.1 6.5
60 9.5 9.8 8.6 8.4 7.9
65 11 13 10 11 9.5
70 15 17 13 13 11
75 19 22 18 14 13
80 22 25 24 15 13
85 23 25 33 15 13
90 20 20 37 14 11
Hip
50 1.2 0.8 1.3 0.7 0.8
55 1.6 1.3 1.5 1.2 1.2
60 2.1 2.2 1.8 1.9 1.8
65 2.9 3.4 2.3 2.9 2.6
70 4.5 5.4 4.1 4.2 3.5
75 7.0 8.3 7.5 5.3 4.6
80 9.6 11 11 5.8 5.4
85 11 12 16 6.7 5.8
90 9.4 9.3 17 7.3 4.5
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respectively) and those of Greece and Turkey (15.4 and
15.9%, respectively) (Table 4).
Discussion
The present study characterised the regional incidence of hip
fracture in a well-defined catchment area. The hip fracture
incidence increased with age in both sexes, but below the
age of 65 years was higher in men than in women.
Thereafter, incidence was higher in women. Similar results
have been reported in many studies including other countries
in Eastern Europe, namely Russia [12], Armenia [11],
Moldova [14] and Belarus, [13]. From these results,
Bulgaria belongs to the moderate risk countries for osteopo-
rotic hip fracture for men and women [28].
Based on the regional incidence, the number of hip frac-
tures in 2015 was estimated at 9322 for the whole country and
is expected to increase by 22% to 11,398 in 2050. These
estimates are relatively robust, in that all individuals who will
be aged 60 years or more in 2050 are currently adults.
However, these estimates may be conservative since they as-
sume that the age- and sex-specific risk of hip fracture remains
unchanged over this period. Decreases in age-specific rates
have occurred in those countries with the higher hip fracture
risks [29], whereas increases in incidence with time are com-
monly found in those countries with the lower risks. It is
estimated that modest increases in secular trends (e.g. 1%
per year) as seen for example in Mexico [9] together with
demographic changes would double the number of hip frac-
tures over 20 years [30]. Such projections are important for
healthcare planning.
The incidence of hip fracture and of death was used to
create a country-specific FRAX model for Bulgaria. Ten-
year probabilities of fracture were consistently higher than
those in the neighbouring countries of Serbia and Romania,
lower than those in Turkey and similar to those in Greece.
These differences in fracture probability cannot be accounted
for by differences in mortality but rather reflect differences in
the risk of hip fracture. Reasons for the heterogeneity in hip
fracture risk are speculative [9]. The factor which best pre-
dicts the heterogeneity in hip fracture risk is socioeconomic
prosperity that in turn may be related to low levels of phys-
ical activity [31]. The fact that there are differences in adja-
cent countries emphasizes the importance of the use of
country-specific FRAX models rather than surrogate models
[32].
A minority of countries that have a FRAXmodel also have
robust information on the risk of other major osteoporotic
fractures. In the absence of such information, FRAX models
are based on the assumption that the age- and sex-specific
pattern of these fractures is similar to that observed in
Malmo, Sweden [33]. The acquisition of data on the incidence
of forearm and humerus fractures in a manner identical to that
for hip fracture permitted the adequacy of this assumption to
be tested, at least for forearm and humeral fractures. Our find-
ings suggest that the incidence of forearm and humerus frac-
tures can be reasonably predicted from the incidence of hip
fracture. Very similar findings have been reported from
Canada [20], Iceland [19], USA [34], UK [35], Australia
[36] and several additional countries of the Western world
and Australia, despite differences in incidence [28]. This com-
monality of pattern is supported by register studies, which
indicate that in those regions where hip fracture rates are high,
so too is the risk of forearm fracture and spine fractures (re-
quiring hospital admission) [37, 38].
In most countries, a case finding approach is used for the
management of osteoporosis, where certain clinical risk fac-
tors (CRFs) for fracture suggest the possible diagnosis of os-
teoporosis and trigger a more detailed assessment of the need
for intervention. Many assessment guidelines recommend that
women with a prior fracture are eligible for treatment. By the
same token, individuals with a fracture probability that is
Table 4 Lifetime probability of hip fracture in the Bulgarian population
from the age of 50 years compared with selected countries
Country Lifetime risk at 50 years (%)a
Women Men
Sweden 25.6 11.0
Denmark 23.0 11.3
France 19.3 5.9
China (Hong Kong) 17.7 7.6
USA (Caucasian) 16.1 7.5
Turkey 15.9 3.6
Canada 15.5 5.8
Greece 15.4 6.8
UK 14.4 5.0
Portugal 13.7 4.8
Finland 12.9 6.0
Spain 12.6 4.2
Bulgariab 11.2 4.4
Hungary 10.8 4.2
Mexico 10.6 5.0
Poland 10.1 4.2
Moldova 9.3 5.7
Russia 7.7 3.8
Serbia 7.7 3.7
Romania 7.1 3.8
China 5.9 3.3
Ukraine 5.6 2.9
a Probabilities derived from fracture as given in FRAX v4.1 and updated
death risks
b Present study
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equivalent to or greater than that of women with a prior frac-
ture should also be eligible. Age-specific intervention thresh-
olds have been widely used in Europe and South America [7].
If the same strategy were used in Bulgaria, the intervention
would be recommended in individuals with a 10-year proba-
bility of a major osteoporotic fracture that ranged from 7.7 to
23%, depending on age (see Table 3).
There are a number of limitations to this study. The accu-
racy of the register is not known. With regard to fracture inci-
dence, we examined somewhat less than 5% of the Bulgarian
population. Therefore, the extrapolation of these regional es-
timations to the entire country is an assumption that we were
unable to test. This would require a national survey and its
validity tested in prospective study of a population-based co-
hort. Moreover, a minority of the population was not included
in the regional health insurance fund and an imbalance in
health status may have skewed our estimates. In addition to
large variations in fracture rates around the world, fracture
rates may vary within countries. In addition to ethnic-
specific differences [39], up to twofold differences in hip frac-
ture incidence have been reported using common methodolo-
gy with the higher rates in urban communities including
Croatia [40], Switzerland [41], Norway [42], Argentina [43]
and Turkey [44].
Despite the well-defined catchment population, it is possi-
ble that not all hip fractures were captured. Indeed, many
patients in Eastern Europe are not hospitalized because facil-
ities for surgical management are limited, so that hospital ad-
mission is not always feasible. In Belarus, for example, 29%
cases of hip fracture did not come to hospital attention [13].
High rates of non-admittance have been reported in Armenia
(44%) [11] Pervouralsk in Russia (27%) [12], Georgia (75%)
and Kyrgyzstan (50%) [45].
It is relevant, however, that accuracy errors have little im-
pact on the rank order with which the FRAX tool categorises
risk in a given population [11, 46], but they do change the
absolute number generated and thus have implications where
treatment guidelines are based on cost-effectiveness or the
economic burden of disease. In order to address these limita-
tions, population representatives of the general population at
risk would need to be studied prospectively, preferably over a
10-year time horizon.
In summary, a FRAX model has been created for Bulgaria
based on a regional population-based estimate of the incidence
of low energy hip fractures. The model should enhance accu-
racy of determining fracture probability among the Bulgarian
population and help to guide decisions about treatment.
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